SCHEMBL4835009

SCHEMBL4835009

COc1cc(OC)c(S(=O)(=O)ON2C(=O)C3CC4C(=O)N(OS(=O)(=O)c5c(OC)cc(OC)cc5OC)C(=O)C4CC3C2=O)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ VDR P11473 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ GAA P10253 1/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ CYP19A1 P11511 1/20 0.33
▸ NQO2 P16083 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ERN1 O75460 1/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829775 0.87 MEN1 (0.41) KMT2AMEN1VDRACHETSHR
SCHEMBL4826503 0.77 GAA (0.49) VDRALDH1A1CYP3A4GAACYP2C19
SCHEMBL4834988 0.76 TSHR (0.49) TSHRALDH1A1CYP3A4LMNACYP2C19
SCHEMBL4835081 0.75 MAPT (0.39) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL4831954 0.72 ALDH1A1 (0.40) KMT2AMEN1VDRACHEALDH1A1
SCHEMBL2677850 0.70 ALDH1A1 (0.47) KMT2AMEN1ACHETSHRALDH1A1
SCHEMBL3825301 0.70 KMT2A (0.55) KMT2AMEN1VDRALDH1A1CYP1A2
SCHEMBL4831741 0.70 — —
SCHEMBL115788 0.67 ERN1 (0.48) ACHEALDH1A1CYP1A2CYP3A4ERN1
SCHEMBL4834426 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 — — US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 — — US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 KMT2A 1016/4885MEN1 211/4885VDR 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback